A Phase 3 Clinical Trial to Evaluate the Safety and Efficacy of HSK39004 Inhalation Suspension in Patients With COPD

Clinical trial NCT07658339 · NOT_YET_RECRUITING

Trial details

NCT number: NCT07658339
Sponsor: Haisco Pharmaceutical Group Co., Ltd.
Status: NOT_YET_RECRUITING
Phase: Phase 3
Study type: INTERVENTIONAL

COPD (Chronic Obstructive Pulmonary Disease)

Start date: 2026-07-11
Primary completion: 2027-06-11
Enrollment: 387

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.